Redhill Biopharma Ltd. - ADR

Redhill Biopharma Ltd. - ADR

RDHL

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.22M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Redhill Biopharma Ltd. - ADRRedhill Biopharma Ltd. - ADR-0.4--218%0.10.3
$0.85

Current Fair Value

27.6% upside

Undervalued by 27.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.22 Million
Enterprise Value$-685,286.00
Dividend Yield$- (-)
Earnings per Share$0
Beta4.97
Outstanding Shares1,803,002

Return

Return on Equity-218.21%ROE
Return on Assets-36.74%
Return on Invested Capital-133.64%

Valuation & Multiples

P/E Ratio-0.35P/E Ratio
PEG-1.04PEG
Price to Sales0.13Price to Sales
Price to Book Ratio0.33Price to Book Ratio
Enterprise Value to Revenue-0.07
Enterprise Value to EBIT0.08
Enterprise Value to Net Income0
Total Debt to Enterprise-1.56
Debt to Equity0.25Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
April 9, 2026
EPS Estimate
$-435.00
Average shareholder expectation
Revenue Estimate
$22.70 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 13, 2026
EPS Estimate
$-352.86
Average shareholder expectation
Revenue Estimate
$24.29 M
Average shareholder expectation

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Redhill Biopharma

CEO: Dror Ben-Asher